Sickle Cell Anemia

Showing 1 - 25 of 122

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sickle Cell Disease, Sickle Cell Anemia, Osteonecrosis Trial (Alendronate Sodium)

Not yet recruiting
  • Sickle Cell Disease
  • +4 more
  • Alendronate Sodium
  • (no location specified)
Sep 6, 2023

Mitapivat in Subjects With Sickle Cell Disease

Enrolling by invitation
  • Sickle Cell Anemia
  • +7 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)

    Recruiting
    • Sickle Cell Anemia
    • Beta Thalassemia
    • TBI
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Secondary Pulmonary Hypertension in Sickle Cell Anemia

    Completed
    • Pulmonary Hypertension
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 26, 2023

      Sickle Cell Anemia Trial in Kingston (Hydroxyurea)

      Recruiting
      • Sickle Cell Anemia
      • Kingston, Jamaica
        Sickle Cell Unit
      Jan 20, 2023

      Sickle Cell Anemia Trial in Santo Domingo (Hydroxyurea, TCD examination)

      Active, not recruiting
      • Sickle Cell Anemia
      • Santo Domingo, Dominican Republic
        Encargada del Servicio de Hematología-Oncología Hospital Infanti
      Jan 17, 2023

      A Long-term Follow-up Study in Subjects Who Received CTX001

      Enrolling by invitation
      • Beta-Thalassemia
      • +6 more
      • CTX001
      • New York, New York
      • +12 more
      Nov 18, 2022

      Bone Pain in Adults With Sickle Cell Disease

      Recruiting
      • Sickle Cell Disease
      • +10 more
        • Sacramento, California
          UC Davis Comprehensive Cancer Center
        Nov 3, 2022

        Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)

        Active, not recruiting
        • Sickle Cell Anemia
        • PBSC Transplant
        • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Oct 13, 2022

        Healthy, Sickle Cell Anemia Trial in United States (Placebo, PF-07209326)

        Recruiting
        • Healthy
        • Sickle Cell Anemia
        • Placebo
        • PF-07209326
        • New Haven, Connecticut
        • +11 more
        Oct 10, 2022

        Sickle Cell Disease, Sickle Cell Anemia, Insomnia Trial run by the National Cancer Institute (NCI) (ACT Intervention, Waitlist)

        Not yet recruiting
        • Sickle Cell Disease
        • +6 more
        • ACT Intervention
        • Waitlist
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 17, 2022

        Sickle Cell Disease, Sickle Cell Anemia Trial run by the NHLBI (Biotin label)

        Recruiting
        • Sickle Cell Disease
        • Sickle Cell Anemia
        • Biotin label
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 11, 2022

        Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)

        Not yet recruiting
        • Beta-Thalassemia
        • +6 more
        • CTX001
        • (no location specified)
        Jul 26, 2022

        Stroke Prevention in Young Adults With Sickle Cell Anemia

        Active, not recruiting
        • Sickle Cell Disease
        • +5 more
        • Hydroxyurea therapy per standard care
        • Nashville, Tennessee
        • +1 more
        Jul 13, 2022

        Sickle Cell Anemia Trial in Paris (Montreal cognitive assessment)

        Not yet recruiting
        • Sickle Cell Anemia
        • Montreal cognitive assessment
        • Paris, France
          Internal Medicine Department - Tenon
        May 20, 2022

        Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA

        Recruiting
        • Sickle Cell Anemia
        • +2 more
        • CD3/CD19 depleted leukocytes
        • +6 more
        • Pittsburgh, Pennsylvania
          Children's Hospital of Pittsburgh of UPMC
        May 4, 2022

        Sickle Cell Disease, Stroke, Neurologic Manifestations Trial in Nashville, Kano (This study does not entail offering any

        Active, not recruiting
        • Sickle Cell Disease
        • +5 more
        • This study does not entail offering any intervention; all data collected will be based on standard of care.
        • Nashville, Tennessee
        • +2 more
        Apr 14, 2022

        Sickle Cell Anemia, Children, Only Trial in United States (Hydroxyurea SDM Toolkit, Clinician Pocket Guide)

        Recruiting
        • Sickle Cell Anemia
        • Children, Only
        • Hydroxyurea SDM Toolkit
        • Clinician Pocket Guide
        • Oakland, California
        • +10 more
        Feb 9, 2022

        Sickle Cell Disease, Sickle Cell Anemia, Stroke Trial in Kano (Moderate Dose Hydroxyurea, Low Dose Hydroxyurea)

        Completed
        • Sickle Cell Disease
        • +2 more
        • Moderate Dose Hydroxyurea
        • Low Dose Hydroxyurea
        • Kano, Nigeria
        • +1 more
        Jan 16, 2022

        Sickle Cell Anemia, Severe Acute Malnutrition Trial in Nashville, Kano (hydroxyurea (20mg/kg/day), Nutritional Supplement)

        Recruiting
        • Sickle Cell Anemia
        • Severe Acute Malnutrition
        • hydroxyurea (20mg/kg/day)
        • Nutritional Supplement
        • Nashville, Tennessee
        • +2 more
        Dec 8, 2021

        Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation

        Recruiting
        • Sickle Cell Disease
        • Sickle Cell Anemia
        • Chart Review
        • Survey
        • Cincinnati, Ohio
          Cincinnati Children's Hospital Medical Center
        Dec 8, 2021

        Sickle Cell Disease, Sickle Cell Anemia Trial in United States (Hydroxyurea)

        Recruiting
        • Sickle Cell Disease
        • Sickle Cell Anemia
        • Phoenix, Arizona
        • +13 more
        Dec 7, 2021

        Sickle Cell Anemia Trial in Worldwide (ACZ885, Placebo)

        Completed
        • Sickle Cell Anemia
        • Atlanta, Georgia
        • +14 more
        Oct 7, 2021

        HbS Disease, Hemoglobin S Disease, Sickle Cell Anemia Trial in Austria, Germany (TCRa/ß+ and CD19+ depleted haploidentical stem

        Recruiting
        • HbS Disease
        • +5 more
        • TCRα/β+ and CD19+ depleted haploidentical stem cell transplantation
        • Matched sibling donor transplantation
        • Düsseldorf, Germany
        • +4 more
        Jul 29, 2021

        Sickle Cell Anemia Trial in United States (Hydroxyurea)

        Completed
        • Sickle Cell Anemia
        • Atlanta, Georgia
        • +3 more
        Jun 3, 2021